Abstract

Retinal Optical Coherence Tomography (OCT) has revolutionized ophthalmic diagnostics, offering high-resolution cross-sectional images of the retina. This modality has led to the identification of various biomarkers in diagnosing and managing retinal diseases. The significance of biomarkers is to provide insights into the structural changes occurring in retina, which are indicative of disease progression or response to treatment.Key biomarkers include retinal layer thickness, presence of intraretinal fluid, subretinal fluid, and hyperreflective foci. These markers are pivotal in conditions such as ARMD, DR, RVO. The detection of specific changes help clinicians determine the necessity and frequency of interventions such as anti-VEGF injections. In conclusion, retinal OCT imaging biomarkers are of immense significance in the realm of ophthalmology. They not only enhance understanding of retinal diseases but play a crucial role in tailoring treatment strategies to improve outcomes.

Talks